Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects
- PMID: 2896013
- PMCID: PMC1386471
- DOI: 10.1111/j.1365-2125.1988.tb03288.x
Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects
Abstract
1. The effects of atenolol administration on maximal exercise capacity and exercise haemodynamics have been compared in eight normotensive and eight mildly hypertensive subjects, matched for sex, age, body weight, and maximal oxygen uptake, and familiar with maximal exercise testing. 2. Supine and exercise blood pressure, and exercise total peripheral resistance were significantly higher, and exercise cardiac output was significantly lower in the hypertensive than in the normotensive subjects. 3. Administration of atenolol (1 X 100 mg day-1) for 3 days reduced supine and exercise systolic blood pressure, heart rate, and cardiac output, and increased exercise stroke volume. Supine and exercise diastolic blood pressure and exercise total peripheral resistance were unaffected by atenolol. The effects of atenolol did not differ in the normotensive and the hypertensive subjects. 4. Maximal work load, maximal oxygen uptake, and maximal heart rate were reduced to a similar extent in normotensive and hypertensive subjects during atenolol treatment. 5. It is concluded that there is no difference in the effects of short-term atenolol administration on exercise haemodynamics and maximal exercise capacity in normotensive and mildly hypertensive subjects.
Similar articles
-
Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.Clin Physiol. 1985 Jun;5(3):231-42. Clin Physiol. 1985. PMID: 2860992 Clinical Trial.
-
Exercise performance during captopril and atenolol treatment in hypertensive patients.Br J Clin Pharmacol. 1991 Dec;32(6):723-8. Br J Clin Pharmacol. 1991. PMID: 1768565 Free PMC article. Clinical Trial.
-
Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.Am J Cardiol. 1985 Apr 26;55(10):135D-141D. doi: 10.1016/0002-9149(85)91070-7. Am J Cardiol. 1985. PMID: 3993545 Clinical Trial.
-
Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs. 1984;28 Suppl 2:35-50. doi: 10.2165/00003495-198400282-00004. Drugs. 1984. PMID: 6151890 Review.
-
Beta-adrenoceptor blockade and exercise. An update.Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002. Sports Med. 1988. PMID: 2897710 Review.
Cited by
-
Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.Eur J Appl Physiol Occup Physiol. 1993;67(5):415-9. doi: 10.1007/BF00376457. Eur J Appl Physiol Occup Physiol. 1993. PMID: 7905412
-
Exercise tolerance with nebivolol and atenolol.Cardiovasc Drugs Ther. 1992 Jun;6(3):239-47. doi: 10.1007/BF00051145. Cardiovasc Drugs Ther. 1992. PMID: 1353367 Clinical Trial.
-
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.Eur J Clin Pharmacol. 1992;42(1):47-53. doi: 10.1007/BF00314919. Eur J Clin Pharmacol. 1992. PMID: 1541316
-
Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.Br J Clin Pharmacol. 2010 Apr;69(4):329-35. doi: 10.1111/j.1365-2125.2009.03577.x. Br J Clin Pharmacol. 2010. PMID: 20406217 Free PMC article. Clinical Trial.
-
Beta-Adrenergic Receptor Blockade Effects on Cardio-Pulmonary Exercise Testing in Healthy Young Adults: A Randomized, Placebo-Controlled Trial.Sports Med Open. 2022 Dec 20;8(1):150. doi: 10.1186/s40798-022-00537-5. Sports Med Open. 2022. PMID: 36538192 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical